Disease Information & Support


The Word:


Generic name Nilotinib
Pronunciation ny-LOH-ti-nib
Brand name(s), other common name(s) Tasigna®
Drug type  Tyrosine kinase inhibitor
How the drug is given By mouth

Nilotinib is FDA approved to treat people who have Philadelphia-chromosome-positive chronic myeloid leukemia in adult patients whose disease could not be treated successfully with other therapies including imatinib (Gleevec®) or who cannot take imatinib.

Side effects needing medical attention: Irregularity in heartbeat; fainting; unexplained bleeding or bruising; blood in urine or stool; unexplained weakness; yellow skin and eyes; shortness of breath; swelling of hands, ankles, feet, or face; sudden stomach area pain with nausea and vomiting; low blood count; rash; nausea; headache; itching; tiredness; diarrhea; constipation.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012